Abstract
Of the known elements, nearly 80% are either metals or metalloids. The highly reactive nature of most metals result in their forming complexes with other compounds such oxygen, sulfide and chloride. Although this reactivity is the primary means by which they are toxic, many metals, in trace amounts, are vital to normal physiological processes; examples include iron in oxygen transport, manganese and selenium in antioxidant defense and zinc in metabolism. With these essential metals toxicity occurs when concentrations are either too low or too high. For some metals there are no physiological concentrations that are beneficial; as such these metals only have the potential to cause toxicity. This chapter focuses on four of these: arsenic, mercury, lead and thallium.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Hunt E, Hader SL, Files D, Corey GR (1999) Arsenic poisoning seen at Duke Hospital, 1965–1998. NC Med J 60: 70–74
Lynch E, Braithwaite R (2005) A review of the clinical and toxicological aspects of ‘traditional’ (herbal) medicines adulterated with heavy metals. Expert Opin Drug Saf 4: 769–778
Wong ST, Chan HL, Teo SK (1998) The spectrum of cutaneous and internal malignancies in chronic arsenic toxicity. Singapore Med J 39: 171–173
Klasco RK (2009) DRUGDEX® System. Thomson Reuters, Greenwood Village, CO (online available at: http://csi.micromedex.com/help/DKS/DKRefEntir.htm)
FDA (2001) Trisenox Consumer Information Sheet. U.S. Food and Drug Administration Center for Drug Evaluation and Research (http://www.fda.gov/)
Vahidnia A, van der Voet GB, de Wolff FA (2007) Arsenic neurotoxicity — A review. Hum Exp Toxicol 26: 823–832
Baselt RC (2002) Disposition of Toxic Drugs and Chemicals in Man. 6th edn., Biomedical Publications, Foster City, CA
Ford M (2006) Arsenic. In: NE Flomenbaum, LR Goldfrank, RS Hoffman, MA Howland, NA Lewin, LS Nelson (eds): Goldfrank’s Toxicologic Emergencies. 8th edn., McGraw-Hill, New York, 1251–1264
ATSDR (2007) Toxicological Profile for Arsenic. U.S. Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry, Atlanta, GA
Peters GR, McCurdy RF, Hindmarsh JT (1996) Environmental aspects of arsenic toxicity. Crit Rev Clin Lab Sci 33: 457–493
Khan MM, Sakauchi F, Sonoda T, Washio M, Mori M (2003) Magnitude of arsenic toxicity in tube-well drinking water in Bangladesh and its adverse effects on human health including cancer: Evidence from a review of the literature. Asian Pac J Cancer Prev 4: 7–14
Jones H, Visoottiviseth P, Bux MK, Fodenyi R, Kovats N, Borbely G, Galbacs Z (2008) Case reports: Arsenic pollution in Thailand, Bangladesh, and Hungary. Rev Environ Contam Toxicol 197: 163–187
Ghosh P, Banerjee M, Giri AK, Ray K (2008) Toxicogenomics of arsenic: Classical ideas and recent advances. Mutat Res 659: 293–301
Vahter M, Concha G (2001) Role of metabolism in arsenic toxicity. Pharmacol Toxicol 89: 1–5
ter Welle HF, Slater EC (1967) Uncoupling of respiratory-chain phosphorylation by arsenate. Biochim Biophys Acta 143: 1–17
Pullen-James S, Woods SE (2006) Occupational arsine gas exposure. J Natl Med Assoc 98: 1998–2001
Vantroyen B, Heilier JF, Meulemans A, Michels A, Buchet JP, Vanderschueren S, Haufroid V, Sabbe M (2004) Survival after a lethal dose of arsenic trioxide. Clin Toxicol 42: 889–895
ATSDR (1990) Case Studies in Environmental Medicine. Arsenic Toxicity. U.S. Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry, Atlanta, GA
Klaassen CD (2006) Heavy metals and heavy-metal antagonists. In: LL Brunton, JS Lazo, KL Parker (eds): Goodman & Gilman’s The Pharmacological Basis of Therapeutics. McGraw-Hill, New York, 1753–1775
Hall JC, Harruff R (1989) Fatal cardiac arrhythmia in a patient with interstitial myocarditis related to chronic arsenic poisoning. South Med J 82: 1557–1560
Beckman KJ, Bauman JL, Pimental PA, Garrard C, Hariman RJ (1991) Arsenic-induced torsade de pointes. Crit Care Med 19: 290–292
Little RE, Kay GN, Cavender JB, Epstein AE, Plumb VJ (1990) Torsade de pointes and T-U wave alternans associated with arsenic poisoning. Pacing Clin Electrophysiol 13: 164–170
Goldsmith S, From AH (1980) Arsenic-induced atypical ventricular tachycardia. N Engl J Med 303: 1096–1098
St Petery J, Gross C, Victorica BE (1970) Ventricular fibrillation caused by arsenic poisoning. Am J Dis Child 120: 367–371
Kishi Y, Sasaki H, Yamasaki H, Ogawa K, Nishi M, Nanjo K (2001) An epidemic of arsenic neuropathy from a spiked curry. Neurology 56: 1417–1418
Donofrio PD, Wilbourn AJ, Albers JW, Rogers L, Salanga V, Greenberg HS (1987) Acute arsenic intoxication presenting as Guillain-Barre-like syndrome. Muscle Nerve 10: 114–120
Heaven R, Duncan M, Vukelja SJ (1994) Arsenic intoxication presenting with macrocytosis and peripheral neuropathy, without anemia. Acta Haematol 92: 142–143
Alain G, Tousignant J, Rozenfarb E (1993) Chronic arsenic toxicity. Int J Dermatol 32: 899–901
Ferreccio C, Sancha AM (2006) Arsenic exposure and its impact on health in Chile. J Health Popul Nutr 24: 164–175
Rahman MM, Ng JC, Naidu R (2009) Chronic exposure of arsenic via drinking water and its adverse health impacts on humans Environ Geochem Health
Ferreccio C, Gonzalez C, Milosavjlevic V, Marshall G, Sancha AM, Smith AH (2000) Lung cancer and arsenic concentrations in drinking water in Chile. Epidemiology 11: 673–679
Mealey J Jr, Brownell GL, Sweet WH (1959) Radioarsenic in plasma, urine, normal tissues, and intracranial neoplasms; distribution and turnover after intravenous injection in man. AMA Arch Neurol Psychiatry 81: 310–320
Stenehjem AE, Vahter M, Nermell B, Aasen J, Lierhagen S, Morland J, Jacobsen D (2007) Slow recovery from severe inorganic arsenic poisoning despite treatment with DMSA (2.3-dimercapto-succinic acid). Clin Toxicol 45: 424–428
Vaziri ND, Upham T, Barton CH (1980) Hemodialysis clearance of arsenic. Clin Toxicol 17: 451–456
FDA (2007) Approved Drug Products. Label for CHEMET. NDA no. 019998 (http://www.fda.gov/)
Kreppel H, Reichl FX, Forth W, Fichtl B (1989) Lack of effectiveness of d-penicillamine in experimental arsenic poisoning. Vet Hum Toxicol 31: 1–5
Klimecki WT, Carter DE (1995) Arsine toxicity: Chemical and mechanistic implications. J Toxicol Environ Health 46: 399–409
Parish GG, Glass R, Kimbrough R (1979) Acute arsine posioning in two workers cleaning a clogged drain. Arch Environ Health 34: 224–227
Ibrahim D, Froberg B, Wolf A, Rusyniak DE (2006) Heavy metal poisoning: Clinical Presentations and pathophysiology. Clin Lab Med 26: 67–97
Fowler BA, Weissberg JB (1974) Arsine poisoning. N Engl J Med 291: 1171–1174
EPA Web Page — Chromated Copper Arsenate (CCA), U.S. Environmental Protection Agency (http://www.epa.gov/)
CPSC (U.S. Consumer Product Safety Commission) Fact Sheet, Chromated Copper Arsenate (CCA) — Treated Wood Used in Playground Equipment, http://www.cpsc.gov/phth/ccafact.html
Hall AH (2002) Chronic arsenic poisoning. Toxicol Lett 128: 69–72
O’Shea JG (1990) “Two minutes with Venus, two years with mercury” — Mercury as an anti-syphilitic chemotherapeutic agent. J R Soc Med 83: 392–395
Risher J, De Woskin R (1999) Toxicological Profile for Mercury Agency for Toxic Substances and Disease Registry (ATSDR), U.S. Department of Health and Human Services, Public Health Service, Atlanta, GA
Goldwater LJ (1955) Hat industry: Mercury; a History of Quicksilver. York Press, Baltimore, MD
Graeme KA, Pollack CV (1998) Heavy metal toxicity, Part I: Arsenic and mercury. J Emerg Med 16: 45–56
Caravati EM, Erdman AR, Christianson G, Nelson LS, Woolf AD, Booze LL, Cobaugh DJ, Chyka PA, Scharman EJ, Manoguerra AS, Troutman WG, American Association of Poison Control Centers (2008) Elemental mercury exposure: An evidence-based consensus guideline for out-of-hospital management. Clin Toxicol 46: 1–21
Bluhm RE, Breyer JA, Bobbitt RG, Welch LW, Wood AJ, Branch RA (1992) Elemental mercury vapour toxicity, treatment, and prognosis after acute, intensive exposure in chloralkali plant workers. Part II: Hyperchloraemia and genitourinary symptoms. Hum Exp Toxicol 11: 211–215
Song Y, Li A (2007) Massive elemental mercury ingestion. Clin Toxicol 45: 193
Rusyniak DE, Nanagas KA (2008) Conservative management of elemental mercury retained in the appendix. Clin Toxicol 46: 831–833
Bredfeldt JE, Moeller DD (1978) Systemic mercury intoxication following rupture of a Miller-Abbott tube. Am J Gastroenterol 69: 478–480
dell’Omo M, Muzi G, Bernard A, Lauwerys RR, Abbritti G (1996) Long-term toxicity of intravenous mercury injection. Lancet 348: 64
Kedziora A, Duflou J (1995) Attempted suicide by intravenous injection of mercury: A rare cause of cardiac granulomas. A case report. Am J Forensic Med Pathol 16: 172–176
Hursh JB, Clarkson TW, Miles EF, Goldsmith LA (1989) Percutaneous absorption of mercury vapor by man. Arch Environ Health 44: 120–127
Boyd AS, Seger D, Vannucci S, Langley M, Abraham JL, King LE Jr (2000) Mercury exposure and cutaneous disease. J Am Acad Dermatol 43: 81–90
Rishler JF, Amler SN (2005) Mercury exposure: Evaluation and intervention in the in appropriate use of chelation agents in the diagnosis and treatment of putative mercury poisoning. Neurotoxicology 26: 691–699
Chang LW, Verity MA (1995) Mercury neurotoxicity: Effects and mechanisms. In: LW Chang, RS Dyer (eds). Handbook of Neurotoxicology. Marcel Dekker, New York, 31–59
Henningsson C, Hoffmann S, McGonigle L (1993) Acute mercury poisoning (acrodynia) mimicking pheochromocytoma in an adolescent. J Pediatr 122: 252–253
Torres AD, Ashok NR, Hardiek ML (2000) Mercury intoxication and arterial hypertension: Report of two patients and review of the literature. Pediatrics 105: E34
Wossmann W, Kohl M, Gruning G, Bucsky P (1999) Mercury intoxication presenting with hypertension and tachycardia. Arch Dis Childhood 80: 556–557
Finkelstein Y, Vardi J, Kesten MM, Hod I (1996) The enigma of parkinsonism in chronic borderline mercury intoxication, resolved by challenge with penicillamine. Neurotoxicology 17: 291–295
Miller K, Ochudlo S, Opala G, Smolicha W, Siuda J (2003) Parkinsonism in chronic occupational metallic mercury intoxication. Neurol Neurochir Pol 37 Suppl 5: 31–38
Ngim CH, Devathasan G (1989) Epidemiologic study on the association between body burden mercury level and idiopathic parkinson’s disease. Neuro epidemiology 8: 128–141
Ohlson CG, Hogstedt C (1981) Parkinson’s disease and occupational exposure to organic solvents, agricultural chemicals and mercury — A case-referent study. Scand J Work Environ Health 7: 252–256
Cornelis R, Heinzow B, Herber R, Christensen J, Paulsen O, Sabbioni E, Templeton D, Thomassen Y, Vahter M, Vesterberg O (1995) Sample collection guidelines for trace elements in blood and urine. Pure Appl Chem 67: 1575–1608
Allain P, Mauras Y, Premel-Cabic A, Islam S, Herve JP, Cledes J (1991) Effects of an EDTA infusion on the urinary elimination of several elements in healthy subjects. Br J Clin Pharmacol 31: 347–349
Sata F, Araki S, Murata K, Aono H (1998) Behavior of heavy metals in human urine and blood following calcium disodium ethylenediamine tetraacetate injection: Observations in metal workers. J Toxicol Environ Health A 54: 167–178
Clarkson TW, Magos L, Myers GJ (2003) The toxicology of mercury — Current exposures and clinical manifestations. N Engl J Med 349: 1731–1737
Kosnett MJ (1992) Unanswered questions in metal chelation. Clin Toxicol 30: 529–547
Clarkson TW, Magos L (2006) The toxicology of mercury and its chemical compounds. Crit Rev Toxicol 36: 609–662
Vimy MJ, Takahashi Y, Lorscheider FL (1990) Maternal-fetal distribution of mercury (203Hg) released from dental amalgam fillings. Am J Physiol 258: R939–945
Mutter J, Naumann J, Guethlin C (2007) Comments on the article “The toxicology of mercury and its chemical compounds” by Clarkson and Magos (2006). Crit Rev Tixicol 37: 537–552
Bates MN, Fawcett J, Garrett N, Cutress T, Kjellstrom T (2004) Health effects of dental amalgam exposure: A retrospective cohort study. Int J Epidemiol 33: 894–902
Bjorkman L, Pedersen NL, Lichtenstein P (1996) Physical and mental health related to dental amalgam fillings in Swedish twins. Commun Dent Oral Epidemiol 24: 260–267
Factor-Litvak P, Hasselgren G, Jacobs D, Begg M, Kline J, Geier J, Mervish N, Schoenholtz S, Graziano J (2003) Mercury derived from dental amalgams and neuropsychologic function. Environ Health Perspect 111: 719–723
Fung YK, Meade AG, Rack EP, Blotcky AJ (1997) Brain mercury in neurodegenerative disorders. J Toxicol Clin Toxicol 35: 49–54
Fung YK, Meade AG, Rack EP, Blotcky AJ, Claassen JP, Beatty MW, Durham T (1996) Mercury determination in nursing home patients with Alzheimer’s disease. Gen Dent 44: 74–78
Nitschke I, Müller F, Smith J, Hopfenmüller W (2000) Amalgam fillings and cognitive abilities in a representative sample of the elderly population. Gerodontology 17: 39–44
Saxe SR, Snowdon DA, Wekstein MW, Henry RG, Grant FT, Donegan SJ, Wekstein DR (1995) Dental amalgam and cognitive function in older women: Findings from the Nun Study. J Am Dent Assoc 126: 1495–1501
Saxe SR, Wekstein MW, Kryscio RJ, Henry RG, Cornett CR, Snowdon DA, Grant FT, Schmitt FA, Donegan SJ, Wekstein DR, Ehmann WD, Markesbery WR (1999) Alzheimer’s disease, dental amalgam and mercury. J Am Dent Assoc 130: 191–199
Langworth S, Bjorkman L, Elinder CG, Jarup L, Savlin P (2002) Multidisciplinary examination of patients with illness attributed to dental fillings. J Oral Rehabil 29: 705–713
Lygre GB, Gjerdet NR, Bjorkman L (2005) A follow-up study of patients with subjective symptoms related to dental materials. Commun Dent Oral Epidemiol 33: 227–234
Berglund A, Molin M (1997) Mercury levels in plasma and urine after removal of all amalgam restorations: The effect of using rubber dams. Dent Mater 13: 297–304
Molin M, Bergman B, Marklund SL, Schutz A, Skerfving S (1990) Mercury, selenium, and glutathione peroxidase before and after amalgam removal in man. Acta Odontol Scand 48: 189–202
DeBont B, Lauwerys R, Govaerts H, Moulin D (1986) Yellow mercuric oxide ointment and mercury intoxication. Eur J Pediatr 145: 217–218
Yip L, Dart R, Sullivan JJ (2001) Mercury. In: JJ Sullivan, G Drieger (eds): Clinical Environmental Health and Toxic Exposures. Lippincott Williams & Wilkins, Philadelphia, PA, 867–879
Dargan P, Giles L, Wallace C, House I, Thomson A, Beale R, Jones A (2003) Case report: Severe mercuric sulphate poisoning treated with 2,3-dimercaptopropane-1-sulphonate and haemodiafiltration. Crit Care 7: R1–R6
Endo T, Nakaya S, Kimura R, Murata T (1984) Gastrointestinal absorption of in organic mercuric compounds in vivo and in situ. Toxicol Appl Pharmacol 74: 223–229
Martin-Gil J, Martin-Gil FJ, Delibes-de-Castro G, Zapatero-Magdaleno P, Sarabia-Herrero FJ (1995) The first known use of vermillion. Experientia 51: 759–761
Sanchez-Sicilia L, Seto D, Nakamoto S, Kolff W (1963) Acute mercurial intoxication treated by hemodialysis. Ann Intern Med 59: 692–706
Schreiner G, Maher J (1965) Toxic nephropathy. Am J Med 38: 409–449
Newton JA, House IM, Volans GN, Goodwin FJ (1983) Plasma mercury during prolonged acute renal failure after mercuric chloride ingestion. Hum Toxicol 2: 535–537
Lund A (1956) The effect various substances on the excretion and the toxicity of thallium in the rat. Acta Pharmacol Toxicol 12: 260–268
Longcope WT, Luetscher JA Jr (1949) The use of BAL in the treatment of the injurious effects of arsenic, mercury and other metallic poisons. Ann Intern Med 31: 545–554
Baker JP (2008) Mercury, vaccines, and autism: One controversy, three histories. Am J Pub Health 98: 244–253
Harada M (1995) Minamata disease: Methylmercury poisoning in Japan caused by environmental pollution. Crit Rev Toxicol 25: 1–24
Bakir F, Damluji SF, Amin-Zaki L, Murtadha M, Khalidi A, al-Rawi NY, Tikriti S, Dahahir HI, Clarkson TW, Smith JC, Doherty RA (1973) Methylmercury poisoning in Iraq. Science 181: 230–241
Aberg B, Ekman L, Falk R, Greitz U, Persson G, Snihs JO (1969) Metabolism of methyl mercury (203Hg) compounds in man. Arch Environ Health 19: 478–484
Berlin M, Carlson J, Norseth T (1975) Dose-dependence of methylmercury metabolism. A study of distribution: Biotransformation and excretion in the squirrel monkey. Arch Environ Health 30: 307–313
Eto K (2000) Minamata disease. Neuropathology 20: S14–19
Eto K, Tokunaga H, Nagashima K, Takeuchi T (2002) An autopsy case of minamata disease (methylmercury poisoning) — Pathological viewpoints of peripheral nerves. Toxicol Pathol 30: 714–722
Harada M (1978) Congenital Minamata disease: Intrauterine methylmercury poisoning. Teratology 18: 285–288
Kondo K (2000) Congenital Minamata disease: Warnings from Japan’s experience. J Child Neurol 15: 458–464
Bakir F, Rustam H, Tikriti S, Al-Damluji SF, Shihristani H (1980) Clinical and epidemiological aspects of methylmercury poisoning. Postgrad Med J 56: 1–10
Nierenberg DW, Nordgren RE, Chang MB, Siegler RW, Blayney MB, Hochberg F, Toribara TY, Cernichiari E, Clarkson T (1998) Delayed cerebellar disease and death after accidental exposure to dimethylmercury. N Engl J Med 338: 1672–1676
Aaseth J, Frieheim EA (1978) Treatment of methyl mercury poisoning in mice with 2,3-dimercaptosuccinic acid and other complexing thiols. Acta Pharmacol Toxicol 42: 248–252
Zimmer LJ, Carter DE (1978) The efficacy of 2,3-dimercaptopropanol and d-penicillamine on methyl mercury induced neurological signs and weight loss. Life Sci 23: 1025–1034
Axton JH (1972) Six cases of poisoning after a parenteral organic mercurial compound (Merthiolate). Postgrad Med J 48: 417–421
Fagan DG, Pritchard JS, Clarkson TW, Greenwood MR (1977) Organ mercury levels in infants with omphaloceles treated with organic mercurial antiseptic. Arch Dis Child 52: 962–964
Lowell JA, Burgess S, Shenoy S, Peters M, Howard TK (1996) Mercury poisoning associated with hepatitis-B immunoglobulin. Lancet 347: 480
Pfab R, Mückter H, Roider G, Zilker T (1996) Clinical course of severe poisoning with thiomersal. J Toxicol Clin Toxicol 34: 453–460
Rohyans J, Walson PD, Wood GA, MacDonald WA (1984) Mercury toxicity following merthiolate ear irrigations. J Pediatr 104: 311–313
Gibson S (1976) Memorandum from Assistant Diretor, Bureau of Biologics, FDA to Director, Bureau of Biologics, FDA entitled “Use of thimerosol in biologics production”. February 27, 1976
Ball LK, Ball R, Pratt RD (2001) An assessment of thimerosal use in childhood vaccines. Pediatrics 107: 1147–1154
Bigham M, Copes R (2005) Thiomersal in vaccines: Balancing the risk of adverse effects with the risk of vaccine-preventable disease. Drug Saf 28: 89–101
Hviid A, Stellfeld M, Wohlfahrt J, Melbye M (2003) Association between thimerosal-containing vaccine and autism. J Am Med Assoc 290: 1763–1766
Thompson WW, Price C, Goodson B, Shay DK, Benson P, Hinrichsen VL, Lewis E, Eriksen E, Ray P, Marcy SM, Dunn J, Jackson LA, Lieu TA, Black S, Stewart G, Weintraub ES, Davis RL, DeStefano F (2007) Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years. N Engl J Med 357: 1281–1292
Verstraeten T, Davis RL, DeStefano F, Lieu TA, Rhodes PH, Black SB, Shinefield H, Chen RT (2003) Safety of thimerosal-containing vaccines: A two-phased study of computerized health maintenance organization databases. Pediatrics 112: 1039–1048
Immunization Safety Review Committee (2004) Vaccines and Autism. The National Academies Press, Institute of Medicine (online available at: http://www.nap.edu/openbook.php?isbn=030909237X)
Global Advisory Committee on Vaccine Safety (2003) Statement on Thimerosal. World Health Organization (online available at: http://www.who.int/vaccine_safety/topics/thiomersal/statment_jul2006/en/index.html)
Lyketsos CG (2003) Should pregnant women avoid eating fish? Lessons from the Seychelles. Lancet 361: 1667–1668
Myers GJ, Davidson PW, Cox C, Shamlaye CF, Palumbo D, Cernichiari E, Sloane-Reeves J, Wilding GE, Kost J, Huang LS, Clarkson TW (2003) Prenatal methylmercury exposure from ocean fish consumption in the Seychelles child development study. Lancet 361: 1686–1692
Davidson PW, Myers GJ, Cox C, Axtell C, Shamlaye C, Sloane-Reeves J, Cernichiari E, Needham L, Choi A, Wang Y, Berlin M, Clarkson TW (1998) Effects of prenatal and postnatal methylmercury exposure from fish consumption on neurodevelopment: Outcomes at 66 months of age in the Seychelles Child Development Study. J Am Med Assoc 280: 701–707
Grandjean P, Weihe P, White RF, Debes F, Araki S, Yokoyama K, Murata K, Sorensen N, Dahl R, Jorgensen PJ (1997) Cognitive deficit in 7-year-old children with prenatal exposure to methylmercury. Neurotoxicol Teratol 19: 417–428
Hernberg S (2000) Lead poisoning in a historical perspective. Am J Ind Med 38: 244–254
Waldron HA (1969) James Hardy and the Devonshire Colic. Med Hist 13: 74–81
Felton JS (1967) Man, medicine, and work in America: A historical series. 3. Benjamin Franklin and his awareness of lead poisoning. J Occup Med 9: 543–554
Jacobs DE, Clickner RP, Zhou JY, Viet SM, Marker DA, Rogers JW, Zeldin DC, Broene P, Friedman W (2002) The prevalence of lead-based paint hazards in U.S. housing. Environ Health Perspect 110: A599–606
CDC (2005) Blood lead levels — United States, 1999–2002. MMWR — Morb Mortal Wkly Rep 54: 513–516
Haley VB, Talbot TO (2004) Seasonality and trend in blood lead levels of New York State children. BMC Pediatr 4: 8
Goldstein GW (1992) Neurologic concepts of lead poisoning in children. Pediatr Ann 21: 384–388
CDC (2004) Lead poisoning from ingestion of a toy necklace — Oregon, 2003. MMWR — Morb Mortal Wkly Rep 53: 509–511
Sokolowski MJ, Sisson G Jr (2005) Systemic lead poisoning due to an intra-articular bullet. Orthopedics 28: 411–412
CDC (1992) Elevated blood lead levels associated with illicitly distilled alcohol — Alabama, 1990–1991. MMWR — Morb Mortal Wkly Rep 41: 294–295
Holstege CP, Ferguson JD, Wolf CE, Baer AB, Poklis A (2004) Analysis of moonshine for contaminants. J Toxicol Clin Toxicol 42: 597–601
Lidsky TI, Schneider JS (2003) Lead neurotoxicity in children: Basic mechanisms and clinical correlates. Brain 126: 5–19
Piomelli S (1981) Chemical toxicity of red cells. Environ Health Perspect 39: 65–70
Albahary C (1972) Lead and hemopoiesis. The mechanism and consequences of the erythropathy of occupational lead poisoning. Am J Med 52: 367–378
Cheson BD, Rom WN, Webber RC (1984) Basophilic stippling of red blood cells: A nonspecific finding of multiple etiology. Am J Ind Med 5: 327–334
Levander OA (1979) Lead toxicity and nutritional deficiencies. Environ Health Perspect 29: 115–125
Loghman-Adham M (1997) Renal effects of environmental and occupational lead exposure. Environ Health Perspect 105: 928–939
Rabinowitz MB (1991) Toxicokinetics of bone lead. Environ Health Perspect 91: 33–37
Rastogi S, Nandlike K, Fenster W (2007) Elevated blood lead levels in pregnant women: Identification of a high-risk population and interventions. J Perinat Med 35: 492–496
Sachs HK (1981) The evolution of the radiologic lead line. Radiology 139: 81–85
Prozialeck WC, Edwards JR, Nebert DW, Woods JM, Barchowsky A, Atchison WD (2008) The vascular system as a target of metal toxicity. Toxicol Sci 102: 207–218
Canfield RL, Henderson CR Jr, Cory-Slechta DA, Cox C, Jusko TA, Lanphear BP (2003) Intellectual impairment in children with blood lead concentrations below 10 microg per deciliter. N Engl J Med 348: 1517–1526
Pocock SJ, Smith M, Baghurst P (1994) Environmental lead and children’s intelligence: A systematic review of the epidemiological evidence. BMJ 309: 1189–1197
Koller K, Brown T, Spurgeon A, Levy L (2004) Recent developments in low-level lead exposure and intellectual impairment in children. Environ Health Perspect 112: 987–994
Henretig FM (2006) Lead. In: NE Flomenbaum, LR Goldfrank, RS Hoffman, MA Howland, NA Lewin, LS Nelson (eds): Goldfrank’s Toxicologic Emergencies. 8th edn., McGraw-Hill, New York, 1308–1334
Cullen MR, Robins JM, Eskenazi B (1983) Adult inorganic lead intoxication: Presentation of 31 new cases and a review of recent advances in the literature. Medicine (Baltimore) 62: 221–247
Baker EL, Feldman RG, White RA, Harley JP, Niles CA, Dinse GE, Berkey CS (1984) Occupational lead neurotoxicity: A behavioural and electrophysiological evaluation. Study design and year one results. Br J Ind Med 41: 352–361
Erenberg G, Rinsler SS, Fish BG (1974) Lead neuropathy and sickle cell disease. Pediatrics 54: 438–441
Nawrot TS, Thijs L, Den Hond EM, Roels HA, Staessen JA (2002) An epidemiological reappraisal of the association between blood pressure and blood lead: A meta-analysis. J Hum Hypertens 16: 123–131
Navas-Acien A, Schwartz BS, Rothenberg SJ, Hu H, Silbergeld EK, Guallar E (2008) Bone lead levels and blood pressure endpoints: A meta-analysis. Epidemiology 19: 496–504
Assennato G, Paci C, Baser ME, Molinini R, Candela RG, Altamura BM, Giorgino R (1987) Sperm count suppression without endocrine dysfunction in lead-exposed men. Arch Environ Health 42: 124–127
Counter SA, Buchanan LH, Ortega F (2004) Current pediatric and maternal lead levels in blood and breast milk in Andean inhabitants of a lead-glazing enclave. J Occup Environ Med 46: 967–973
IARC (1987) Overall Evaluation of Carcinogenicity: An Updating of IARC Monographs, Vols. 1 to 42. International Agency for Research on Cancer (IARC), Lyon, 230–232
Steenland K, Boffetta P (2000) Lead and cancer in humans: Where are we now? Am J Ind Med 38: 295–299
Boeckx RL, Postl B, Coodin FJ (1977) Gasoline sniffing and tetraethyl lead poisoning in children. Pediatrics 60: 140–145
Anderson MK, Amrich M, Decker KL, Mervis CA (2007) Using state lead poisoning surveillance system data to assess false positive results of capillary testing. Matern Child Health J 11: 603–610
Martin CJ, Werntz CL 3rd, Ducatman AM (2004) The interpretation of zinc protoporphyrin changes in lead intoxication: A case report and review of the literature. Occup Med 54: 587–591
Hu H, Shih R, Rothenberg S, Schwartz BS (2007) The epidemiology of lead toxicity in adults: Measuring dose and consideration of other methodologic issues. Environ Health Perspect 115: 455–462
American Academy of Pediatrics Committee on Environmental Health (2005) Lead exposure in children: Prevention, detection, and management. Pediatrics 116: 1036–1046
Yeoh B, Woolfenden S, Wheeler D, Alperstein G, Lanphear B (2008) Household interventions for prevention of domestic lead exposure in children. Cochrane Database Syst Rev: CD006047
Rogan WJ, Dietrich KN, Ware JH, Dockery DW, Salganik M, Radcliffe J, Jones RL, Ragan NB, Chisolm JJ Jr, Rhoads GG (2001) The effect of chelation therapy with succimer on neuropsychological development in children exposed to lead. N Engl J Med 344: 1421–1426
De Groot G, van Heijst AN, van Kesteren RG, Maes RA (1985) An evaluation of the efficacy of charcoal haemoperfusion in the treatment of three cases of acute thallium poisoning. Arch Toxicol 57: 61–66
Besunder JB, Super DM, Anderson RL (1997) Comparison of dimercaptosuccinic acid and calcium disodium ethylenediaminetetraacetic acid versus dimercaptopropanol and ethylenediaminetetraacetic acid in children with lead poisoning. J Pediatr 130: 966–971
Brown MJ, Willis T, Omalu B, Leiker R (2006) Deaths resulting from hypocalcemia after administration of edetate disodium: 2003–2005. Pediatrics 118: e534–536
Lehmann PA, Favari L (1984) Parameters for the adsorption of thallium ions by activated charcoal and Prussian blue. J Toxicol Clin Toxicol 22: 331–339
De Backer W, Zachee P, Verpooten GA, Majelyne W, Vanheule A, De Broe ME (1982) Thallium intoxication treated with combined hemoperfusion-hemodialysis. J Toxicol Clin Toxicol 19: 259–264
Hologgitas J, Ullucci P, Driscoll J, Grauerholz J, Martin H (1980) Thallium elimination kinetics in acute thallotoxicosis. J Anal Toxicol 4: 68–75
Clifton JC 2nd, Sigg T, Burda AM, Leikin JB, Smith CJ, Sandler RH (2002) Acute pediatric lead poisoning: Combined whole bowel irrigation, succimer therapy, and endoscopic removal of ingested lead pellets. Pediatr Emerg Care 18: 200–202
James FA (1984) Of ‘Medals and Muddles’ the context of the discovery of thallium: William Crookes’s early spectro-chemical work. Notes Rec R Soc Lond 39: 65–90
Douglas KT, Bunni MA, Baindur SR (1990) Thallium in biochemistry. Int J Biochem 22: 429–438
Gehring PJ, Hammond PB (1967) The interrelationship between thallium and potassium in animals. J Pharmacol Exp Ther 155: 187–201
Melnick RL, Monti LG, Motzkin SM (1976) Uncoupling of mitochondrial oxidative phosphorylation by thallium. Biochem Biophy Res Commun 69: 68–73
Mulkey JP, Oehme FW (1993) A review of thallium toxicity. Vet Hum Toxicol 35: 445–453
Lund A (1956) Distribution of thallium in the organism and its elimination. Acta Pharmacol Toxicol 12: 251–259
Malbrain ML, Lambrecht GL, Zandijk E, Demedts PA, Neels HM, Lambert W, De Leenheer AP, Lins RL, Daelemans R (1997) Treatment of severe thallium intoxication. J Toxicol Clin Toxicol 35: 97–100
Reed D, Crawley J, Faro SN, Pieper SJ, Kurland LT (1963) Thallotoxicosis. J Am Med Assoc 183
Rusyniak DE, Furbee RB, Kirk MS (2002) Thallium and arsenic poisoning in a small midwest town. Ann Emerg Med 39: 307–311
Meggs WJ, Hoffman RS, Shih RD, Weisman RS, Goldfrank LR (1994) Thallium poisoning from maliciously contaminated food. J Toxicol Clin Toxicol 32: 723–730
Misra UK, Kalita J, Yadav RK, Ranjan P (2003) Thallium poisoning: Emphasis on early diagnosis and response to haemodialysis. Postgrad Med J 79: 103–105
Chamberlain PH, Stavinoha WB, Davis H, Kniker WT, Panos TC (1958) Thallium poisoning. Pediatrics 22: 1170–1182
Desenclos JC, Wilder MH, Coppenger GW, Sherin K, Tiller R, van Hook RM (1992) Thallium poisoning: An outbreak in Florida, 1988. South Med J 85: 1203–1206
Prick JJG, Sillevis Smitt WG, Muller L (1955) Thallium Poisoning. Elsevier Publishing, Amsterdam
Cavanagh JB, Fuller NH, Johnson HRM (1974) The effects of thallium salts, with particular reference to the nervous system changes. A report of three cases. Q J Med 170: 293–319
Davis LE, Standefer JC, Kornfeld M, Abercrombie DM, Butler C (1980) Acute thallium poisoning: Toxicological and morphological studies of the nervous system. Ann Neurol 10: 38–44
Hoffman RS (2003) Thallium toxicity and the role of Prussian blue in therapy. Toxicol Rev 22: 29–40
Tabandeh H, Crowston JG, Thompson GM (1994) Ophthalmologic features of thallium poisoning. Am J Ophthal 117: 243–245
Feldman J, Levisohn DR (1993) Acute alopecia: Clue to thallium toxicity. Pediatr Dermatol 10: 29–31
Heyl T, Barlow RJ (1989) Thallium poisoning: A dermatological perspective. Br J Dermatol 121: 787–791
Moeschlin S (1980) Thallium poisoning. Clin Toxicol 17: 133–146
Koblenzer PJ, Weiner LB (1969) Alopecia secondary to thallium intoxication. Arch Dermatol 99: 777
Cavanagh JB, Gregson M (1978) Some effects of a thallium salt on the proliferation of hair follicle cells. J Pathol 125: 179–191
Tromme I, van Neste D, Dobbelaere F, Bouffioux B, Courtin C, Dugernier T, Pierre P, Dupuis M (1998) Skin signs in the diagnosis of thallium poisoning. Br J Dermatol 138: 321–325
Saha A, Sadhu HG, Karnik AB, Patel TS, Sinha SN, Saiyed HN (2004) Erosion of nails following thallium poisoning: A case report. Occup Environ Med 61: 640–642
Bank WJ, Pleasure DE, Suzuki K, Nigro M, Katz R (1972) Thallium poisoning. Arch Neurol 26: 456–464
Roby DS, Fein AM, Bennett RH, Morgan LS, Zatuchni J, Lippmann ML (1984) Cardiopulmonary effects of acute thallium poisoning. Chest 85: 236–240
Moore D, House I, Dixon A (1993) Thallium poisoning. Diagnosis may be elusive but alopecia is the clue. BMJ 306: 1527–1529
Cavanagh JB (1979) The ‘dying back’ process. A common denominator in many naturally occurring and toxic neuropathies. Arch Pathol Lab Med 103: 659–664
Cavanagh JB (1991) What have we learnt from Graham Frederick Young? Reflections on the mechanism of thallium neurotoxicity. Neuropathol Appl Neurobiol 17: 3–9
Metter D, Vock R (1984) [Structure of the hair in thallium poisoning]. Zeitschr Rechtsmed J Leg Med 91: 201–214
Wecht C, Saitz G (2007) Mortal Evidence: The Forensics Behind Nine Shocking Cases. Prometheus Books, New York
Barroso-Moguel R, Villeda-Hernandez J, Mendez-Armenta M, Rios C, Monroy-Noyola A (1994) Combinet d-penicillamine and Prussian blue as antidotal treatment against thallotoxicosis in rats: Evaluation of cerebellar lesions. Toxicology 89: 15–24
Heydlauf H (1969) Ferric-cyanoferrate (II): An effective antidote in thallium poisoning. Eur J Pharmacol 6: 340–344
Kamerbeek HH, Rauws AG, ten Ham M, van Heijst AN (1971) Dangerous redistribution of thallium by treatment with sodium diethyldithiocarbamate. Acta Med Scand 189: 149–154
Manninen V, Malkonen M, Skulskii IA (1976) Elimination of thallium in rats as influenced by Prussian blue and sodium chloride. Acta Pharmacol Toxicol 39: 256–261
Meggs WJ, Cahill-Morasco R, Shih RD, Goldfrank LR, Hoffman RS (1997) Effects of Prussian blue and N-acetylcysteine on thallium toxicity in mice. J Toxicol Clin Toxicol 35: 163–166
Rauws AG (1974) Thallium pharmacokinetics and its modification by Prussian blue. Naunyn Schmiedebergs Arch Pharmacol 284: 295–306
Rios C, Monroy-Noyola A (1992) d-Penicillamine and Prussian blue as antidotes against thallium intoxication in rats. Toxicology 74: 69–76
Rusyniak DE, Kao LW, Nanagas KA, Kirk MA, Furbee RB, Brizendine EJ, Wilmot PE (2003) Dimercaptosuccinic acid and Prussian blue in the treatment of acute thallium poisoning in rats. J Toxicol Clin Toxicol 41: 137–142
Pearce J (1994) Studies of any toxicological effects of Prussian blue compounds in mammals — A review. Food Chem Toxicol 32: 577–582
Lund A (1956) The effect various substances on the excretion and the toxicity of thallium in the rat. Acta Pharmacol Toxicol 12: 260–268
Mulkey JP, Oehme FW (2000) Are 2,3-dimercapto-1-propanesulfonic acid or Prussian blue beneficial in acute thallotoxicosis in rats? Vet Hum Toxicol 42: 325–329
Van der Stock J, Schepper J (1978) The effect of Prussian blue and sodium-ethylenediaminetetraacetic acid on the faecal and urinary elimination of thallium by the dog. Res, Vet Sci 25: 337–342
Hoffman RS, Stringer JA, Feinberg RS, Goldfrank LR (1999) Comparative efficacy of thallium adsorption by activated charcoal, Prussian blue, and sodium polystyrene sulfonate. J Toxicol Clin Toxicol 37: 833–837
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Birkhäuser Verlag/Switzerland
About this chapter
Cite this chapter
Rusyniak, D.E., Arroyo, A., Acciani, J., Froberg, B., Kao, L., Furbee, B. (2010). Heavy metal poisoning: management of intoxication and antidotes. In: Luch, A. (eds) Molecular, Clinical and Environmental Toxicology. Experientia Supplementum, vol 100. Birkhäuser Basel. https://doi.org/10.1007/978-3-7643-8338-1_11
Download citation
DOI: https://doi.org/10.1007/978-3-7643-8338-1_11
Publisher Name: Birkhäuser Basel
Print ISBN: 978-3-7643-8337-4
Online ISBN: 978-3-7643-8338-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)